Warren C Bogard, Jr

Title: Warren C. Bogard, Jr.: Innovator in Monoclonal Antibody Research

Introduction

Warren C. Bogard, Jr. is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work has implications for the treatment and detection of gram-negative bacteria, which are known to cause serious infections.

Latest Patents

Warren C. Bogard, Jr. holds a patent for "Mammalian monoclonal antibodies against endotoxin of gram-negative." This patent describes mammalian monoclonal anti-lipopolysaccharide (LPS) antibodies that react with gram-negative bacteria across different genera. The anti-LPS antibodies are useful for the treatment or prevention of gram-negative bacteremia and for the detection of gram-negative microorganisms. He has 1 patent to his name.

Career Highlights

Warren is currently associated with Centocor, Inc., a company known for its innovative approaches in biotechnology and pharmaceuticals. His work at Centocor has allowed him to focus on developing solutions that address critical health challenges posed by gram-negative bacteria.

Collaborations

Warren has collaborated with Patrick C. Kung, who is also involved in similar research areas. Their combined expertise contributes to advancements in the understanding and treatment of bacterial infections.

Conclusion

Warren C. Bogard, Jr. is a distinguished inventor whose work in monoclonal antibodies has the potential to significantly impact medical science. His contributions are vital in the ongoing fight against bacterial infections.